John Leite
Known title: Global Chief Commercial OffCIK: 0001991536
Associated companies
Transaction History
| VCYT | ▼ Sell | Open Market | 4,015 | $161K | 9/21/2026 | View on chart |
| VCYT | ▼ Sell | Tax Withholding | 3,961 | $178K | 9/2/2026 | View on chart |
| VCYT | ▼ Sell | Open Market | 13,975 | $700K | 6/4/2026 | View on chart |
| VCYT | ▼ Sell | Tax Withholding | 4,059 | $194K | 6/2/2026 | View on chart |
| VCYT | ▲ Buy | Grant | 36,181 | $0 | 3/6/2026 | View on chart |
| VCYT | ▲ Buy | Grant | 6,578 | $0 | 3/6/2026 | View on chart |
| VCYT | ▼ Sell | Open Market | 5,260 | $185K | 3/4/2026 | View on chart |
| VCYT | ▼ Sell | Tax Withholding | 7,517 | $271K | 3/2/2026 | View on chart |
| VCYT | ▲ Buy | Grant | 47,149 | $0 | 2/26/2026 | View on chart |
| VCYT | ▼ Sell | Tax Withholding | 8,905 | $345K | 2/26/2026 | View on chart |
| VCYT | ▼ Sell | Open Market | 1,278 | $61K | 12/4/2025 | View on chart |
| VCYT | ▼ Sell | Tax Withholding | 2,900 | $134K | 12/2/2025 | View on chart |
| VCYT | ▼ Sell | Open Market | 2,808 | $140K | 11/25/2025 | View on chart |
| VCYT | ▼ Sell | Open Market | 2,539 | $89K | 10/1/2025 | View on chart |
| VCYT | ▼ Sell | Tax Withholding | 2,902 | $87K | 9/2/2025 | View on chart |
| VCYT | ▼ Sell | Open Market | 2,809 | $76K | 6/4/2025 | View on chart |
| VCYT | ▼ Sell | Tax Withholding | 2,900 | $78K | 6/2/2025 | View on chart |
| VCYT | ▼ Sell | Open Market | 2,400 | $74K | 3/7/2025 | View on chart |
| VCYT | ▼ Sell | Open Market | 5,011 | $160K | 3/7/2025 | View on chart |
| VCYT | ▲ Buy | Grant | 36,240 | $0 | 3/6/2025 | View on chart |
| VCYT | ▼ Sell | Tax Withholding | 7,650 | $266K | 3/2/2025 | View on chart |
| VCYT | ▼ Sell | Open Market | 5,746 | $194K | 2/27/2025 | View on chart |
| VCYT | ▲ Buy | Grant | 11,006 | $0 | 2/27/2025 | View on chart |
| VCYT | ▼ Sell | Open Market | 1,050 | $45K | 12/3/2024 | View on chart |
| VCYT | ▼ Sell | Tax Withholding | 1,314 | $58K | 12/2/2024 | View on chart |
| VCYT | ▼ Sell | Open Market | 5,479 | $163K | 9/4/2024 | View on chart |
| VCYT | ▼ Sell | Tax Withholding | 1,315 | $41K | 9/2/2024 | View on chart |
| VCYT | ▼ Sell | Open Market | 1,277 | $32K | 7/16/2024 | View on chart |
| VCYT | ▼ Sell | Tax Withholding | 1,314 | $27K | 6/2/2024 | View on chart |
| VCYT | ▲ Buy | Grant | 49,880 | $0 | 3/6/2024 | View on chart |
| VCYT | ▼ Sell | Tax Withholding | 3,008 | $72K | 3/2/2024 | View on chart |
| VCYT | ▼ Sell | Tax Withholding | 556 | $15K | 12/2/2023 | View on chart |
| VCYT | ▼ Sell | Tax Withholding | 2,222 | $59K | 9/2/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 11, 2026
Veracyte (VCYT) Stock Seen as Undervalued After 107% Rise
Recent coverage notes that Veracyte’s shares have risen more than 100% while still appearing inexpensive relative to its earnings multiple. The company’s trailing P/E of about 30.6 and an analyst consensus target near $58 suggest the market may be pricing in further upside. The stock is currently trading near the lower end of its 52‑week range, close to a support level that has been tested multiple times.
Veracyte (VCYT) Stock Seen as Undervalued After 107% Rise. Recent coverage notes that Veracyte’s shares have risen more than 100% while still appearing inexpensive relative to its earnings multiple. The company’s trailing P/E of about 30.6 and an analyst consensus target near $58 suggest the market may be pricing in further upside. The stock is currently trading near the lower end of its 52‑week range, close to a support level that has been tested multiple times.